Literature DB >> 20167214

Identification and properties of complexes formed by myeloperoxidase with lipoproteins and ceruloplasmin.

Alexej V Sokolov1, Kira V Ageeva, Olga S Cherkalina, Maria O Pulina, Elena T Zakharova, Vladimir N Prozorovskii, Denis V Aksenov, Vadim B Vasilyev, Oleg M Panasenko.   

Abstract

The first evidence of multi-component complexes formed by myeloperoxidase (MPO), ceruloplasmin (CP), and very low/low density lipoproteins (VLDL/LDL) obtained by electrophoresis, gel filtration, and photon-correlation spectroscopy (PCS) is presented in this paper. Complexes were observed when isolated MPO, CP, and VLDL/LDL were mixed and/or when MPO was added to the blood plasma. Complex LDL-MPO-CP was detected in 44 of 100 plasma samples taken from patients with atherosclerosis, and 33 of 44 samples also contained the VLDL-MPO-CP complex. MPO concentration in these patients' plasma exceeded 800 ng/ml. Interaction of MPO with high density lipoproteins (HDL) was not revealed, as well as binding of CP to lipoproteins in the absence of MPO. Adding antibodies against apoB-100 to VLDL-MPO-CP and LDL-MPO-CP complexes results in release of lipoproteins. Using PCS the diameters of complexes under study were evaluated. By comparing concentrations of the components in complexes formed by MPO, CP, and lipoproteins their stoichiometry was assessed as 2VLDL:1MPO:2CP and 1LDL:1MPO:2CP. Lipoproteins affected the inhibition of MPO peroxidase activity by CP. The affinity of lipoproteins to MPO-CP complex was assessed using apparent dissociation constants determined as approximately 0.3 nM for VLDL and approximately 0.14 nM for LDL. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167214     DOI: 10.1016/j.chemphyslip.2010.02.002

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  13 in total

Review 1.  Pondering neutrophil extracellular traps with healthy skepticism.

Authors:  William M Nauseef; Paul Kubes
Journal:  Cell Microbiol       Date:  2016-08-23       Impact factor: 3.715

2.  Ceruloplasmin is an endogenous inhibitor of myeloperoxidase.

Authors:  Anna L P Chapman; Tessa J Mocatta; Sruti Shiva; Antonia Seidel; Brian Chen; Irada Khalilova; Martina E Paumann-Page; Guy N L Jameson; Christine C Winterbourn; Anthony J Kettle
Journal:  J Biol Chem       Date:  2013-01-10       Impact factor: 5.157

3.  Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention.

Authors:  Michael J Davies
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

4.  Native low density lipoprotein promotes lipid raft formation in macrophages.

Authors:  Jian Song; Ling-Yan Ping; Duc M Duong; Xiao-Yan Gao; Chun-Yan He; Lei Wei; Jun-Zhu Wu
Journal:  Mol Med Rep       Date:  2016-01-14       Impact factor: 2.952

Review 5.  Chlorinated Phospholipids and Fatty Acids: (Patho)physiological Relevance, Potential Toxicity, and Analysis of Lipid Chlorohydrins.

Authors:  Jenny Schröter; Jürgen Schiller
Journal:  Oxid Med Cell Longev       Date:  2016-12-20       Impact factor: 6.543

6.  Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase.

Authors:  Tina Nybo; Simon Dieterich; Luke F Gamon; Christine Y Chuang; Astrid Hammer; Gerald Hoefler; Ernst Malle; Adelina Rogowska-Wrzesinska; Michael J Davies
Journal:  Redox Biol       Date:  2018-11-03       Impact factor: 11.799

7.  Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.

Authors:  Cédric Delporte; Karim Zouaoui Boudjeltia; Caroline Noyon; Paul G Furtmüller; Vincent Nuyens; Marie-Christine Slomianny; Philippe Madhoun; Jean-Marc Desmet; Pierre Raynal; Damien Dufour; Chintan N Koyani; Florence Reyé; Alexandre Rousseau; Michel Vanhaeverbeek; Jean Ducobu; Jean-Claude Michalski; Jean Nève; Luc Vanhamme; Christian Obinger; Ernst Malle; Pierre Van Antwerpen
Journal:  J Lipid Res       Date:  2014-02-17       Impact factor: 5.922

Review 8.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

9.  Myeloperoxidase modulates human platelet aggregation via actin cytoskeleton reorganization and store-operated calcium entry.

Authors:  Irina V Gorudko; Alexey V Sokolov; Ekaterina V Shamova; Natalia A Grudinina; Elizaveta S Drozd; Ludmila M Shishlo; Daria V Grigorieva; Sergey B Bushuk; Boris A Bushuk; Sergey A Chizhik; Sergey N Cherenkevich; Vadim B Vasilyev; Oleg M Panasenko
Journal:  Biol Open       Date:  2013-07-26       Impact factor: 2.422

10.  Iron Together with Lipid Downregulates Protein Levels of Ceruloplasmin in Macrophages Associated with Rapid Foam Cell Formation.

Authors:  Qi Wang; Jiajie Ji; Shuangying Hao; Meng Zhang; Kuanyu Li; Tong Qiao
Journal:  J Atheroscler Thromb       Date:  2016-03-31       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.